[시장보고서]세계의 차세대 시퀀싱 라이브러리 조제 시장 : 시퀀싱 유형(표적 게놈 시퀀싱, 전게놈 시퀀싱), 제품, 용도, 최종사용자, 지역별 예측(2022-2032년)

세계의 차세대 시퀀싱 라이브러리 조제 시장 : 시퀀싱 유형(표적 게놈 시퀀싱, 전게놈 시퀀싱), 제품, 용도, 최종사용자, 지역별 예측(2022-2032년)

Global Next-generation Sequencing Library Preparation Market Size study, by Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), by Product, by Application, by End-use, and Regional Forecasts 2022-2032

상품코드 : 1729130

리서치사 : Bizwit Research & Consulting LLP

발행일 : 2025년 05월

페이지 정보 : 영문 285 Pages

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 차세대 시퀀싱(NGS) 라이브러리 조제 시장 규모는 2023년 약 15억 7,000만 달러에서 예측 기간 중 13.00% 이상의 CAGR로 성장할 것으로 예측됩니다.

NGS 라이브러리 준비는 현대 유전체학의 핵심이며, 시퀀싱 워크플로우에서 중요한 준비 단계로서 유전 정보 출력의 효율성, 깊이 및 품질을 좌우하는 중요한 준비 단계입니다. NGS가 임상 진단, 암 연구, 감염병 모니터링, 농업 유전체학 등 다양한 분야로 확대됨에 따라 강력하고 처리량이 높으며 자동화된 라이브러리 준비 솔루션에 대한 수요가 급증하고 있습니다. 빠르게 증가하고 있습니다. 연구자와 임상의들은 입력량을 최소화하고, 오류를 줄이며, 여러 타겟을 동시에 분석할 수 있는 간소화된 워크플로우를 선택하고 있으며, 이는 확대되는 유전체학 생태계에서 라이브러리 전처리 기술의 중요성을 더욱 높이고 있습니다.

시장 성장은 몇 가지 변혁적인 요인에 의해 주도되고 있습니다. 정밀의료와 맞춤 치료에 대한 수요가 증가함에 따라 표적 유전체 시퀀싱과 전장 유전체 시퀀싱에 대한 요구가 증가하고 있으며, 이 두 가지 모두 효율적인 라이브러리 준비 프로토콜에 크게 의존하고 있습니다. 제약사 및 연구기관들은 데이터 재현성과 처리량을 향상시키기 위해 첨단 시약, 자동화 플랫폼 및 통합 시스템에 투자하고 있습니다. 또한 비드 기반 노멀라이제이션, 트랜스포자제(transposase), 효소 조각화 등의 혁신 기술을 통해 데이터의 무결성을 유지하면서 처리 시간을 단축할 수 있습니다. 그러나 기술적 발전에도 불구하고 시퀀싱 인프라에 대한 초기 투자 비용과 일부 라이브러리 준비 키트의 기술적 복잡성, 열화 또는 소량의 샘플을 처리할 때 발생하는 기술적 복잡성 등이 시장 성장의 걸림돌로 작용하고 있습니다.

시장 상황에 영향을 미치는 주요 동향 중 하나는 라이브러리 준비 시스템의 소형화 및 다중화 기능에 대한 관심이 높아지고 있다는 점입니다. 이러한 변화는 대규모 집단 연구 및 임상시험에서 NGS를 보다 확장 가능하고 비용 효율적으로 만드는 것을 목표로 하고 있습니다. 기업은 여러 시퀀싱 플랫폼을 지원하고 혈액, FFPE 조직, 미생물 DNA 등 다양한 시료 유형에 적용할 수 있는 올인원 라이브러리 준비 키트를 개발하기 위해 경쟁하고 있습니다. 또한 라이브러리 준비 단계의 품질관리에 머신러닝 알고리즘을 통합하는 움직임이 주목받고 있으며, 이러한 솔루션은 사용자가 시퀀싱 결과를 예측하고 프로토콜을 최적화할 수 있도록 돕습니다. 자동화, 인포매틱스, 소모품의 혁신이 결합하여 연구와 임상 모두에 필요한 차세대 툴의 물결이 전 세계에서 확산되고 있습니다.

세계의 차세대 시퀀싱 라이브러리 조제 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인의 분석, 법규제 환경, 시장 규모 추이·예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

북미
- 미국
- 캐나다
유럽
- 영국
- 독일
- 프랑스
- 스페인
- 이탈리아
- 기타
아시아태평양
- 중국
- 인도
- 일본 시장
- 호주
- 한국
- 기타
라틴아메리카
- 브라질
- 멕시코
- 기타
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 기타

제10장 경쟁 정보

주요 기업의 SWOT 분석
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
주요 시장 전략
기업 개요
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- QIAGEN NV
- PerkinElmer, Inc.
- New England Biolabs
- F. Hoffmann La Roche Ltd.
- Takara Bio Inc.
- BGI Group
- Bio Rad Laboratories, Inc.
- Oxford Nanopore Technologies
- Integrated DNA Technologies(IDT)
- Zymo Research Corporation
- Pacific Biosciences of California, Inc.
- Nugen Technologies, Inc.

제11장 조사 프로세스

KSA

영문 목차

영문목차

The Global Next-generation Sequencing (NGS) Library Preparation Market is valued approximately at USD 1.57 billion in 2023 and is anticipated to grow with a compound annual growth rate of more than 13.00% over the forecast period 2024-2032. NGS library preparation lies at the heart of modern genomics, acting as a critical preliminary step in the sequencing workflow that determines the efficiency, depth, and quality of genetic data output. The process involves the fragmentation of nucleic acids and the addition of specialized adapters to facilitate sequencing. As the applications of NGS broaden across clinical diagnostics, oncology, infectious disease surveillance, and agricultural genomics, the demand for robust, high-throughput, and automation-friendly library preparation solutions is accelerating significantly. Researchers and clinicians are increasingly opting for streamlined workflows that minimize input quantity, reduce errors, and enable simultaneous analysis of multiple targets, all of which amplify the significance of library preparation technologies in the expanding genomics ecosystem.

The market growth is driven by several transformative factors. The rise in demand for precision medicine and personalized therapies has escalated the need for targeted genome and whole genome sequencing-two major applications that depend heavily on efficient library preparation protocols. Pharmaceutical companies and research laboratories are investing in advanced reagents, automation platforms, and integrated systems to enhance data reproducibility and throughput. Furthermore, innovations such as bead-based normalization, transposase-based methods, and enzymatic fragmentation are reducing turnaround times while preserving data integrity. However, despite technological advancements, market growth is partially hindered by challenges like high initial capital expenditure for sequencing infrastructure and the technical complexity associated with some library prep kits, especially when dealing with degraded or limited input samples.

A key trend influencing the landscape is the growing focus on miniaturization and multiplexing capabilities in library prep systems. This shift is aimed at improving the scalability and cost-effectiveness of NGS for large population studies and clinical trials. Companies are racing to develop all-in-one library prep kits compatible with multiple sequencing platforms and adaptable to a wide range of sample types-from blood to FFPE tissue to microbial DNA. Additionally, the integration of machine learning algorithms for quality control during library prep stages is gaining traction. These solutions are enabling end-users to predict sequencing outcomes and optimize protocols, further enhancing reliability. The confluence of automation, informatics, and consumables innovation is thus driving a wave of next-gen tools that address both research and clinical needs across the globe.

Regionally, North America remains the epicenter of the NGS library preparation market, primarily due to its strong presence of genomic research institutions, significant funding from NIH and other agencies, and early adoption of clinical NGS. The United States in particular has established a mature ecosystem of NGS service providers, life science tool manufacturers, and academic collaborators. Europe follows closely, supported by large-scale genomic initiatives in countries like the UK, Germany, and the Netherlands. Meanwhile, Asia Pacific is projected to be the fastest-growing region, spurred by government-led genomic projects in China and India, increasing healthcare investments, and the presence of a growing number of CROs and clinical diagnostic companies. These developments across geographies signify a global shift towards genomics-enabled healthcare and data-driven life sciences.

Major market player included in this report are:

Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
PerkinElmer, Inc.
New England Biolabs
F. Hoffmann-La Roche Ltd.
Takara Bio Inc.
BGI Group
Bio-Rad Laboratories, Inc.
Oxford Nanopore Technologies
Integrated DNA Technologies (IDT)
Zymo Research Corporation
Pacific Biosciences of California, Inc.
Nugen Technologies, Inc.

The detailed segments and sub-segment of the market are explained below:

By Sequencing Type

Targeted Genome Sequencing
Whole Genome Sequencing

By Product

Kits
Reagents
Instruments
Others

By Application

Oncology
Infectious Disease
Genetic Testing
Reproductive Health
Others

By End-use

Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Laboratories
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Next generation Sequencing Library Preparation Market Executive Summary

1.1. Global Next generation Sequencing Library Preparation Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Sequencing Type
- 1.3.2. By Product
- 1.3.3. By Application
- 1.3.4. By End use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Next generation Sequencing Library Preparation Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Next generation Sequencing Library Preparation Market Dynamics

3.1. Market Drivers
- 3.1.1. Escalating Demand for Precision Medicine and Personalized Oncology
- 3.1.2. Innovations in Automation and Enzymatic Library Prep
- 3.1.3. Expansion of NGS Applications in Infectious Disease and Agriculture
3.2. Market Challenges
- 3.2.1. High Capital Expenditure for Sequencing Infrastructure
- 3.2.2. Technical Complexity with Degraded or Low Input Samples
- 3.2.3. Supply Chain Constraints for Specialized Reagents
3.3. Market Opportunities
- 3.3.1. Miniaturization and Multiplexing to Reduce Per Sample Cost
- 3.3.2. Growth in Emerging Markets (APAC, Latin America)
- 3.3.3. Integration of AI Driven QC and Protocol Optimization

Chapter 4. Global Next generation Sequencing Library Preparation Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Next generation Sequencing Library Preparation Market Size & Forecasts by Sequencing Type 2022-2032

5.1. Segment Dashboard
5.2. Global Market: Sequencing Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Targeted Genome Sequencing
- 5.2.2. Whole Genome Sequencing

Chapter 6. Global Next generation Sequencing Library Preparation Market Size & Forecasts by Product 2022-2032

6.1. Segment Dashboard
6.2. Global Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Kits
- 6.2.2. Reagents
- 6.2.3. Instruments
- 6.2.4. Others

Chapter 7. Global Next generation Sequencing Library Preparation Market Size & Forecasts by Application 2022-2032

7.1. Segment Dashboard
7.2. Global Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Oncology
- 7.2.2. Infectious Disease
- 7.2.3. Genetic Testing
- 7.2.4. Reproductive Health
- 7.2.5. Others

Chapter 8. Global Next generation Sequencing Library Preparation Market Size & Forecasts by End use 2022-2032

8.1. Segment Dashboard
8.2. Global Market: End use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 8.2.1. Academic and Research Institutes
- 8.2.2. Pharmaceutical and Biotechnology Companies
- 8.2.3. Hospitals and Diagnostic Laboratories
- 8.2.4. Others

Chapter 9. Global Next generation Sequencing Library Preparation Market Size & Forecasts by Region 2022-2032

9.1. North America Market
- 9.1.1. U.S. Market
  - 9.1.1.1. Sequencing Type breakdown size & forecast, 2022-2032
  - 9.1.1.2. Product breakdown size & forecast, 2022-2032
- 9.1.2. Canada Market
9.2. Europe Market
- 9.2.1. U.K. Market
- 9.2.2. Germany Market
- 9.2.3. France Market
- 9.2.4. Spain Market
- 9.2.5. Italy Market
- 9.2.6. Rest of Europe Market
9.3. Asia Pacific Market
- 9.3.1. China Market
- 9.3.2. India Market
- 9.3.3. Japan Market
- 9.3.4. Australia Market
- 9.3.5. South Korea Market
- 9.3.6. Rest of Asia Pacific Market
9.4. Latin America Market
- 9.4.1. Brazil Market
- 9.4.2. Mexico Market
- 9.4.3. Rest of Latin America Market
9.5. Middle East & Africa Market
- 9.5.1. Saudi Arabia Market
- 9.5.2. South Africa Market
- 9.5.3. Rest of Middle East & Africa Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
- 10.1.1. Illumina, Inc.
- 10.1.2. Thermo Fisher Scientific Inc.
- 10.1.3. Agilent Technologies, Inc.
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Illumina, Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Thermo Fisher Scientific Inc.
- 10.3.3. Agilent Technologies, Inc.
- 10.3.4. QIAGEN N.V.
- 10.3.5. PerkinElmer, Inc.
- 10.3.6. New England Biolabs
- 10.3.7. F. Hoffmann La Roche Ltd.
- 10.3.8. Takara Bio Inc.
- 10.3.9. BGI Group
- 10.3.10. Bio Rad Laboratories, Inc.
- 10.3.11. Oxford Nanopore Technologies
- 10.3.12. Integrated DNA Technologies (IDT)
- 10.3.13. Zymo Research Corporation
- 10.3.14. Pacific Biosciences of California, Inc.
- 10.3.15. Nugen Technologies, Inc.

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes